Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panels 1-4), Request for Applications (RFA) DP07-002, 19933 [E7-7502]

Download as PDF Federal Register / Vol. 72, No. 76 / Friday, April 20, 2007 / Notices Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 1 p.m.–4 p.m., June 11, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, Special Interest Project Competitive Supplements (Panels 5– 6),’’ RFA DP07–002. Contact Person for More Information: Susan Goodman, D.D.S., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE., Mailstop D74, Atlanta, GA 30333, Telephone 404–639–4940. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 13, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7500 Filed 4–19–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers: Special Interest Project Competitive Supplements (Panels 1–4), Request for Applications (RFA) DP07–002 sroberts on PROD1PC70 with NOTICES In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned Special Emphasis Panel. Time and Date: 8:30 a.m.–5 p.m., June 19, 2007 (Closed). Place: Doubletree Buckhead, 3342 Peachtree Road, NE., Atlanta, Georgia 30326. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and VerDate Aug<31>2005 18:52 Apr 19, 2007 Jkt 211001 evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, Special Interest Project Competitive Supplements (Panels 1– 4),’’ RFA DP07–002. Contact Person for More Information: Juliana Cyril, M.P.H., PhD., Associate Director for Policy and Peer Review, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE., Mailstop D74, Atlanta, GA 30333, Telephone 404–639–4939. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 13, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7502 Filed 4–19–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): The Sexual Networks of African American STI Repeaters, an Elaboration of Risk, Potential Extramural Project (PEP) 2007–R–01 and Dynamic Mathematical Modeling of Sexual Transmission of C. Trachomatis Transmission in the United States, Evaluating Impact on Prevention Strategies on Chlamydial Incidence, Prevalence and Sequelae, PEP 2007–R–02 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12 p.m.–2 p.m., May 15, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘The Sexual Networks of African American STI Repeaters, an Elaboration of Risk,’’ PEP 2007–R–01, and ‘‘Dynamic Mathematical Modeling of Sexual Transmission of C. Trachomatis Transmission in the United States, Evaluating Impact on Prevention Strategies on Chlamydial Incidence, Prevalence and Sequelae,’’ PEP 2007–R–02. Contact Person for More Information: Susan Goodman, D.D.S., Scientific Review PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 19933 Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE., Mailstop D74, Atlanta, GA 30333, Telephone 404–639–4940. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 13, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–7503 Filed 4–19–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Health Promotion and Disease Prevention Research Centers, Special Interest Project Competitive Supplements (Panels 9–11), Request for Applications (RFA) DP07–002 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 8:30 a.m.–5 p.m., June 18, 2007 (Closed). Place: Doubletree Buckhead, 3342 Peachtree Road NE, Atlanta, GA 30326, telephone 404–321–1234. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Pub. L. 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Health Promotion and Disease Prevention Research Centers, Special Interest Project Competitive Supplements (Panels 9– 11),’’ RFA DP07–002. Contact Person for More Information: Juliana Cyril, M.P.H., PhD, Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE., Mailstop D74, Atlanta, GA 30333, Telephone 404–639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for E:\FR\FM\20APN1.SGM 20APN1

Agencies

[Federal Register Volume 72, Number 76 (Friday, April 20, 2007)]
[Notices]
[Page 19933]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-7502]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Health Promotion and Disease Prevention Research 
Centers: Special Interest Project Competitive Supplements (Panels 1-4), 
Request for Applications (RFA) DP07-002

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting of the aforementioned Special 
Emphasis Panel.

    Time and Date: 8:30 a.m.-5 p.m., June 19, 2007 (Closed).
    Place: Doubletree Buckhead, 3342 Peachtree Road, NE., Atlanta, 
Georgia 30326.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c) (4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of ``Health Promotion and Disease 
Prevention Research Centers, Special Interest Project Competitive 
Supplements (Panels 1-4),'' RFA DP07-002.
    Contact Person for More Information: Juliana Cyril, M.P.H., 
PhD., Associate Director for Policy and Peer Review, Office of the 
Chief Science Officer, CDC, 1600 Clifton Road NE., Mailstop D74, 
Atlanta, GA 30333, Telephone 404-639-4939.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 13, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
 [FR Doc. E7-7502 Filed 4-19-07; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.